← Oncology Approval Tracker

FDA DECISION ·

Keytruda

pembrolizumab · Merck

FDA approvalNew or expanded indicationMelanoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adjuvant treatment for adults and children age 12 and older with stage IIB or IIC melanoma after complete resection.

LAMPGEN ANALYSIS

Why it matters

The action broadens postoperative immunotherapy to specified high-risk stage II melanoma populations.

What research teams should watch

Verify surgical pathology, stage and resection completeness before applying the historical eligibility criteria.

PRIMARY RECORDS

Sources